Mesa Laboratories, Inc. (MLAB) News
Filter MLAB News Items
MLAB News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest MLAB News From Around the Web
Below are the latest news stories about MESA LABORATORIES INC that investors may wish to consider to help them evaluate MLAB as an investment opportunity.
Mesa Laboratories Inc (MLAB) Reports 9.5% Decrease in Q2 FY 2024 RevenuesCompany's Adjusted Operating Income Declines by 29.1% Quarter Over Quarter |
Mesa Labs Announces Second Quarter ResultsLAKEWOOD, Colo., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its second fiscal quarter (“2Q24”) ended September 30, 2023. Second quarter FY 2024 compared to second quarter FY 2023: Revenues decreased 9.5% but increased 5.0% vs 1Q24Non-GAAP core organic revenues3 decreased 10.1% but increased 2.7% vs. 1Q24Operating income decreased |
Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa’s SDC PlatformLakewood, Colo., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us” or “our”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the completed acquisition of GKE-GmbH’s sterilization indicators business and its accredited, independent testing lab SAL GmbH. Additionally, Mesa has entered into a definitive agreement to purchase GKE’s Chinese sales entity, Beijing GKE Science & Techn |
Shareholders in Mesa Laboratories (NASDAQ:MLAB) are in the red if they invested three years agoInvesting in stocks inevitably means buying into some companies that perform poorly. But long term Mesa Laboratories... |
MESA LABS DECLARES QUARTERLY DIVIDENDLAKEWOOD, Colo., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15, 2023, to shareholders of record at the close of business on November 30, 2023. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacturing of life science tools and critical quali |
Penumbra and Mesa Labs have been highlighted as Zacks Bull and Bear of the DayPenumbra and Mesa Labs are part of the Zacks Bull and Bear of the Day article. |
Bear of the Day: Mesa Labs (MLAB)Mesa diagnostics gains importance among big pharma so we want to watch this dip |
Insider Sell: Director John Schmieder Sells 3,000 Shares of Mesa Laboratories IncOn September 13, 2023, John Schmieder, a director at Mesa Laboratories Inc (NASDAQ:MLAB), sold 3,000 shares of the company's stock. |
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023LAKEWOOD, Colo., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Monday, November 6, 2023. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers |
15 Worst Performing Growth Stocks in 2023In this piece, we will take a look at the fifteen worst performing growth stocks in 2023. If you want to skip details about different kinds of investing strategies, then check out 5 Worst Performing Growth Stocks in 2023. Growth stocks have the potential to deliver strong returns in the future if the economy and […] |